Form 8-K - Current report:
SEC Accession No. 0001213900-24-095102
Filing Date
2024-11-07
Accepted
2024-11-06 19:19:57
Documents
15
Period of Report
2024-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0218947-8k_rafael.htm   iXBRL 8-K 38768
2 PRESS RELEASE, DATED NOVEMBER 6, 2024, REPORTING THE RESULTS OF OPERATIONS FOR T ea021894701ex99-1_rafael.htm EX-99.1 88549
3 GRAPHIC ex99-1_001.jpg GRAPHIC 2871
  Complete submission text file 0001213900-24-095102.txt   314266

Data Files

Seq Description Document Type Size
4 XBRL LABEL FILE rfl-20241106_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE rfl-20241106_pre.xml EX-101.PRE 22370
6 XBRL SCHEMA FILE rfl-20241106.xsd EX-101.SCH 3030
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0218947-8k_rafael_htm.xml XML 3557
Mailing Address 520 BROAD STREET NEWARK NJ 07120
Business Address 520 BROAD STREET NEWARK NJ 07120 212-658-1450
Rafael Holdings, Inc. (Filer) CIK: 0001713863 (see all company filings)

EIN.: 822296593 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-38411 | Film No.: 241432638
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)